胸腔积液中环氧化酶-2与血管内皮生长因子的表达及临床意义

doi:10.3877/cma.j.issn.1674-0785.2017.14.002

中华临床医师杂志(电子版) ›› 2017, Vol. 11 ›› Issue (14) : 2019 -2022. doi: 10.3877/cma.j.issn.1674-0785.2017.14.002

所属专题：文献；

临床论著

胸腔积液中环氧化酶-2与血管内皮生长因子的表达及临床意义

赵方正¹, 郑新华², 黄传君², 邓鹏辉³, 宫晓丹⁴, 张才擎⁵^,^†(

)

^1. 250355　济南，山东中医药大学2015级研究生；250014　济南，山东省千佛山医院呼吸内科
^2. 250355　济南，山东中医药大学2015级研究生
^3. 271000　泰安，泰山医学院
^4. 250014　济南，山东大学医学院
^5. 250014　济南，山东省千佛山医院呼吸内科

收稿日期:2017-03-07 出版日期:2017-07-15
通信作者: 张才擎
基金资助:
山东省自然科学基金(ZR2013HM046)

Clinical significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in pleural effusion

Fangzheng Zhao¹, Xinhua Zheng², Chuanjun Huang², Penghui Deng³, Xiaodan Gong⁴, Caiqing Zhang⁵^,^†()

^1. Shandong University of Traditional Chinese Medicine, Jinan 250355, China; Department of Respiratory Medicine, Shandong Provincial Qianfoshan Hospital, Jinan 250014, China
^2. Shandong University of Traditional Chinese Medicine, Jinan 250355, China
^3. Taishan Medical University, Taian 271000, China
^4. School of Medicine, Shandong University, Jinan 250014, China
^5. Department of Respiratory Medicine, Shandong Provincial Qianfoshan Hospital, Jinan 250014, China

Received:2017-03-07 Published:2017-07-15
Corresponding author: Caiqing Zhang
About author:
Corresponding author: Zhang Caiqing, Email: freezcq66@163.com

全文 ( ) 下载PDF ( ) 导出引用

引用本文：

赵方正, 郑新华, 黄传君, 邓鹏辉, 宫晓丹, 张才擎. 胸腔积液中环氧化酶-2与血管内皮生长因子的表达及临床意义[J]. 中华临床医师杂志(电子版), 2017, 11(14): 2019-2022.

Fangzheng Zhao, Xinhua Zheng, Chuanjun Huang, Penghui Deng, Xiaodan Gong, Caiqing Zhang. Clinical significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in pleural effusion[J]. Chinese Journal of Clinicians(Electronic Edition), 2017, 11(14): 2019-2022.

目的

通过胸腔积液中环氧化酶-2（COX-2）及血管内皮生长因子（VEGF）含量的测定，探讨COX-2、VEGF对良恶性胸腔积液的鉴别诊断价值及意义。

方法

选取于2015年6月至2016年8月在山东省千佛山医院就诊并确诊的48例恶性胸腔积液、10例良性胸腔积液，酶联免疫吸附法（ELISA法）测定胸腔积液中COX-2、VEGF的表达水平，比较COX-2、VEGF在良恶性胸腔积液中表达的差异。

结果

48例恶性胸腔积液及10例良性胸腔积液中COX-2、VEGF表达量与性别、年龄无明显关系（P>0.05）。恶性胸腔积液中COX-2、VEGF表达量为（788.04±128.85）U/L、（365.27±80.63）ng/L，良性胸腔积液中COX-2、VEGF表达量为（366.92±41.08）U/L、（114.67±15.69）ng/L，恶性胸腔积液中COX-2、VEGF表达水平显著高于良性胸腔积液，差异具有统计学意义（P<0.001）。

结论

恶性胸腔积液中COX-2、VEGF的表达显著高于良性胸腔积液，有望成为良恶性胸腔积液鉴别诊断的有效指标。

关键词: 环氧化酶-2, 血管内皮生长因子, 胸腔积液, 肿瘤

Objective

To assess the significance of COX-2 and VEGF in the differential diagnosis of benign and malignant pleural effusions by detecting their levels in pleural effusion.

Methods

Fifty-eight cases of pleural effusion were collected at our hospital, including 48 cases of malignant pleural effusion and 10 cases of benign pleural effusion. Expression levels of COX-2 and VEGF in pleural effusions were detected by ELISA and compared between benign and malignant pleural effusions.

Results

The expression levels of COX-2 and VEGF had no significant association with gender or age in both 48 cases of malignant pleural effusion and 10 cases of benign pleural effusion (P>0.05). The average COX-2 and VEGF levels were (788.04 ± 128.85) U/L and (365.27 ± 80.63) ng/L, respectively, in the malignant pleural effusion group, and the corresponding values in the benign pleural effusion group were (366.92 ± 41.08) U/L and (114.67 ± 15.69) ng/L. COX-2 and VEGF levels in malignant pleural effusion were significantly higher than those in benign pleural effusion (P<0.001).

Conclusion

COX-2 and VEGF expression levels are higher in malignant pleural effusion than in benign pleural effusion, and they may serve as prognostic factors to distinguish between benign and malignant pleural effusions.

Key words: Cyclooxygenase-2, Vascular endothelial growth factor, Pleural effusion, Tumor

表1 2组胸腔积液中COX-2、VEGF含量的比较（±s）

组别	例数	COX-2（U/L）	VEGF（?ng?/L）
试验组	48	788.04±128.85	365.27±80.63
对照组	10	366.92±41.08	114.67±15.69
P值	?	＜0.05	＜0.05

表1 2组胸腔积液中COX-2、VEGF含量的比较（±s）

组别	例数	COX-2（U/L）	VEGF（?ng?/L）
试验组	48	788.04±128.85	365.27±80.63
对照组	10	366.92±41.08	114.67±15.69
P值	?	＜0.05	＜0.05

表2 不同肿瘤组胸腔积液COX-2、VEGF含量的比较（±s）

肿瘤类型	例数	COX-2（U/L）	VEGF（?ng?/L）	r值	P值
肺癌	23	847.21±131.89^a	403.12±89.23^a	0.89	＜0.05
乳腺癌	11	759.35±97.16^a	330.22±38.57^a	0.78	＜0.05
肝癌	6	710.33±95.38^a	307.05±57.93^a	0.91	＜0.05
胃癌	8	676.89±62.74^a	365.98±39.12^a	0.77	＜0.05
结核性胸膜炎	10	368.52±39.97	115.03±16.25	?	?

表2 不同肿瘤组胸腔积液COX-2、VEGF含量的比较（±s）

肿瘤类型	例数	COX-2（U/L）	VEGF（?ng?/L）	r值	P值
肺癌	23	847.21±131.89^a	403.12±89.23^a	0.89	＜0.05
乳腺癌	11	759.35±97.16^a	330.22±38.57^a	0.78	＜0.05
肝癌	6	710.33±95.38^a	307.05±57.93^a	0.91	＜0.05
胃癌	8	676.89±62.74^a	365.98±39.12^a	0.77	＜0.05
结核性胸膜炎	10	368.52±39.97	115.03±16.25	?	?

[1]	阮光强，王羡强，陈国军, 等. 胸水中VEGF、TNF-α的检测对良恶性胸水的鉴别诊断意义 [J]. 现代生物医学进展, 2012, 12(15):2952-2953,2958.
[2]	Antonangelo L, Sales RK, Corá AP, et al. Pleural fluid tumour markers in malignant pleural effusion with inconclusive cytologic results [J]. Curr Oncol, 2015, 22(5):336-341.
[3]	Cheng F, Wang Q, Zhong D. Value of cell block in the diagnosis of malignant pleural effusion [J]. Zhongguo Fei Ai Za Zhi, 2015, 18(10):652-655.
[4]	Wasilewicz MP, Kołodziej B, Bojułko T, et al. Expression of cyclooxygenase-2 in colonic polyps [J]. Pol Arch Med Wewn, 2010, 120(9):313-320.
[5]	Fiorelli A, Vicidomini G, Di Domenico M, et al. Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications [J]. Interact Cardiovasc Thorac Surg, 2011, 12(3):420-424.
[6]	徐杰，齐大亮，李绪斌, 等. 重组人血管内皮抑制素联合化疗治疗非小细胞肺癌恶性胸腔积液的疗效观察 [J]. 中国肿瘤临床, 2014, 41(24):1573-1576.
[7]	Hooper C, Lee YC, Maskell N. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010 [J]. Thorax, 2010, 65(2):4-17.
[8]	Qu L, Liu B. Cyclooxygeanse-2 promotes metastasis in osteosarcoma [J]. Cancer Cell Int, 2015, 15(1):69-75.
[9]	Singh-Ranger G, Giordano P. A COX-2 inhibitor combined with chemoradiation of locally advanced rectal cancer [J]. Int J Colorectal Dis, 2009, 24(7):863.
[10]	Lobo PK, Vu L, Chan SK, et al. Predictive utility of cyclooxygenase-2 expression by colon and rectal cancer [J]. Am J Surg, 2014, 207(5):712-716.
[11]	Gou HF, Chen XC, Zhu J, et al. Expressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implications [J]. J Exp Clin Cancer Res, 2011, 30(9):14-18.
[12]	Elzagheid A, Emaetig F, Alkikhia L, et al. High cyclooxygenase-2 expression is associated with advanced stages in colorectal cancer [J]. Anticancer Res, 2013, 33(8):3137-3143.
[13]	Weidner N. Introtumor microvessel density as a prognostic factor in cancer [J]. Am J Pathol, 1995, 147(1):9-19.
[14]	Alevizakos M, Kaltsas S, Syrigos KN. The VEGF pathway in lung cancer [J]. Cancer Chemother Pharmacol, 2013, 72(6):1169-1181.
[15]	Brown LF, Berse B, Jackman RW, et al. Expression of vascular permeability factor(vascular endothelial growth factor)and its receptors in adenocarcinomas of the gastrointestinal tract [J]. Cancer Res, 1993, 53(19):4727-4735.
[16]	Yano S, Herbst RS, Shinohara H, et al. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation [J]. Clin Cancer Res, 2000, 6(3):957-965.
[17]	Christoph B. Transforming growth factor-β1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular cancer cell [J]. Cancer Res, 2003, 63(5):1083-1092.
[18]	Yuan A, Yu CJ, Shun CT, et al. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients [J]. Int J Cancer, 2005, 115(4):545-555.

[1]	韩丹, 王婷, 肖欢, 朱丽容, 陈镜宇, 唐毅. 超声造影与增强CT对儿童肝脏良恶性病变诊断价值的对比分析[J]. 中华医学超声杂志（电子版）, 2023, 20(09): 939-944.
[2]	郏亚平, 曾书娥. 含鳞状细胞癌成分的乳腺化生性癌的超声与病理特征分析[J]. 中华医学超声杂志（电子版）, 2023, 20(08): 844-848.
[3]	燕速, 霍博文, 徐惠宁. 4K荧光腹腔镜扩大右半结肠CME+D3根治术及No.206、No.204组淋巴结清扫术[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 14-14.
[4]	钱龙, 陆晓峰, 王行舟, 杜峻峰, 沈晓菲, 管文贤. 神经系统调控胃肠道肿瘤免疫应答研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 86-89.
[5]	曹长青, 郭新艳, 高源, 张存, 唐海利, 樊东, 杨小军, 张松, 赵华栋. 肿瘤微环境参与介导HER2阳性乳腺癌曲妥珠单抗耐药的研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 90-95.
[6]	姚宏伟, 魏鹏宇, 高加勒, 张忠涛. 不断提高腹腔镜右半结肠癌D3根治术的规范化[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 1-4.
[7]	杜晓辉, 崔建新. 腹腔镜右半结肠癌D3根治术淋巴结清扫范围与策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 5-8.
[8]	周岩冰, 刘晓东. 腹腔镜右半结肠癌D3根治术消化道吻合重建方式的选择[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 9-13.
[9]	唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[10]	张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[11]	张焱辉, 张蛟, 朱志贤. 留置肛管在中低位直肠癌新辅助放化疗后腹腔镜TME术中的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 25-28.
[12]	李凤仪, 李若凡, 高旭, 张超凡. 目标导向液体干预对老年胃肠道肿瘤患者术后血流动力学、胃肠功能恢复的影响[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 29-32.
[13]	李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[14]	王军, 刘鲲鹏, 姚兰, 张华, 魏越, 索利斌, 陈骏, 苗成利, 罗成华. 腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 844-849.
[15]	徐军, 姬园园, 陈君平, 王健. 伴菊形团结构的脑膜瘤合并颅骨侵犯一例并文献复习[J]. 中华临床医师杂志(电子版), 2023, 17(08): 916-919.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Clinical significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in pleural effusion

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Clinical significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in pleural effusion